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Spinal cord injury (SCI) affects 6 million people worldwide with no available treatment. Despite research advances, the inherent
poor regeneration potential of the central nervous system remains a major hurdle. Small RNAs 19-33 nucleotides in length are a
set of non-coding RNA molecules that regulate gene expression and have emerged as key players in regulating cellular events
occurring after SCI. Here we profiled a class of small RNA known as microRNAs (miRNAs) following SCI in the cortex where the cell
bodies of corticospinal motor neurons are located. We identified miR-7b-3p as a candidate target given its significant upregulation
after SCI in vivo and we screened by miRWalk PTM the genes predicted to be targets of miR-7b-3p (among which we identified
Wipf2, a gene regulating neurite extension). Moreover, sixteen genes, involved in neural regeneration and potential miR-7b-3p
targets, were found to be downregulated in the cortex following SCI. We also analysed miR-7b-3p function during cortical neuron
development in vitro: we observed that the overexpression of miR-7b-3p was important 1) to maintain neurons in a more
immature and, likely, plastic neuronal developmental phase and 2) to contrast the apoptotic pathway; however, in normal
conditions it did not affect the Wipf2 expression. On the contrary, the overexpression of miR-7b-3p upon in vitro oxidative stress
condition (mimicking the SCI environment) significantly reduced the expression level of Wipf2, as observed in vivo, confirming it as
a direct miR-7b-3p target.
Overall, these data suggest a dual role of miR-7b-3p: i) the induction of a more plastic neuronal condition/phase, possibly at the
expense of the axon growth, ii) the neuroprotective role exerted through the inhibition of the apoptotic cascade. Increasing the
miR-7b-3p levels in case of SCI could reactivate in adult neurons silenced developmental programs, supporting at the same time the
survival of the axotomized neurons.
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occurring after SCI. Here we profiled a class of small RNA known as microRNAs (miRNAs) following SCI in the cortex where the cell
bodies of corticospinal motor neurons are located. We identified miR-7b-3p as a candidate target given its significant upregulation
after SCI in vivo and we screened by miRWalk PTM the genes predicted to be targets of miR-7b-3p (among which we identified
Wipf2, a gene regulating neurite extension). Moreover, sixteen genes, involved in neural regeneration and potential miR-7b-3p
targets, were found to be downregulated in the cortex following SCI. We also analysed miR-7b-3p function during cortical neuron
development in vitro: we observed that the overexpression of miR-7b-3p was important 1) to maintain neurons in a more
immature and, likely, plastic neuronal developmental phase and 2) to contrast the apoptotic pathway; however, in normal
conditions it did not affect the Wipf2 expression. On the contrary, the overexpression of miR-7b-3p upon in vitro oxidative stress
condition (mimicking the SCI environment) significantly reduced the expression level of Wipf2, as observed in vivo, confirming it as
a direct miR-7b-3p target. Overall, these data suggest a dual role of miR-7b-3p: i) the induction of a more plastic neuronal
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Spinal cord injury (SCI) affects 6 million people worldwide with no available treatment. 26 
Despite research advances, the inherent poor regeneration potential of the central nervous 27 
system remains a major hurdle. Small RNAs 19-33 nucleotides in length are a set of non-coding 28 
RNA molecules that regulate gene expression and have emerged as key players in regulating 29 
cellular events occurring after SCI. Here we profiled a class of small RNA known as 30 
microRNAs (miRNAs) following SCI in the cortex where the cell bodies of corticospinal motor 31 
neurons are located. We identified miR-7b-3p as a candidate target given its significant 32 
upregulation after SCI in vivo and we screened by miRWalk PTM the genes predicted to be 33 
targets of miR-7b-3p (among which we identified Wipf2, a gene regulating neurite extension). 34 
Moreover, sixteen genes, involved in neural regeneration and potential miR-7b-3p targets, were 35 
found to be downregulated in the cortex following SCI. We also analysed miR-7b-3p function 36 
during cortical neuron development in vitro: we observed that the overexpression of miR-7b-37 
3p was important 1) to maintain neurons in a more immature and, likely, plastic neuronal 38 
developmental phase and 2) to contrast the apoptotic pathway; however, in normal conditions 39 
it did not affect the Wipf2 expression. On the contrary, the overexpression of miR-7b-3p upon 40 
in vitro oxidative stress condition (mimicking the SCI environment) significantly reduced the 41 
expression level of Wipf2, as observed in vivo, confirming it as a direct miR-7b-3p target.  42 
Overall, these data suggest a dual role of miR-7b-3p: i) the induction of a more plastic neuronal 43 
condition/phase, possibly at the expense of the axon growth, ii) the neuroprotective role exerted 44 
through the inhibition of the apoptotic cascade. Increasing the miR-7b-3p levels in case of SCI 45 
could reactivate in adult neurons silenced developmental programs, supporting at the same time 46 









Around 6 million people worldwide live with a significant disability caused by traumatic spinal 52 
cord injury (SCI), which is associated with devastating social impact plus huge economic cost 53 
(Singh et al., 2014). Immediately after a SCI event, timely surgical intervention is critical to 54 
stabilise the lesion. The glial scar that forms at the site of the lesion produced by reactive 55 
astrocytes delimiting the area becomes a temporal obstacle for axon regeneration. When 56 
therapeutic strategies are applied at later stages, they are generally ineffective. The 57 
acute/intermediate phase when the formation of glial scar is not yet complete is an appropriate 58 
window to efficiently promote the regeneration process (Tran et al., 2018). Motor disabilities 59 
that follow SCI trauma are essentially due to axotomised corticospinal fibres [corticospinal 60 
motor neurons (CSMNs) whose cell body is located in the layer V of the cortex] that are unable 61 
to re-establish functional connections. Despite CSMN attempts to regenerate, their efforts fail 62 
because of a non-permissive regrowth environment, neurotrophic factor deprivation and 63 
inhibitory myelin-associated molecules (Brown and Martinez, 2019; Xu et al., 2019a). No 64 
successful treatment is available for SCI patients although several therapeutic interventions 65 
such as cell engraftment, 3D scaffolds and gene therapy are currently under investigation. 66 
These interventions aim to reduce glial scar formation and to promote neuronal regeneration 67 
(Assinck et al., 2017; Boido et al., 2019; Cofano et al., 2019; Zhang et al., 2019).  68 
In the last two decades, a class of small RNA (sRNA) gene regulatory molecules termed 69 
microRNAs (miRNAs) emerged as promising targets in SCI. miRNAs are transcripts ~22 70 
nucleotides  in length that bind to the 3’UTR of target messenger RNA (mRNA) leading to 71 
translational inhibition (Green et al., 2016; Pinchi et al., 2019). miRNAs are abundantly 72 
expressed in the central nervous system (CNS) with specific temporal and spatial patterns 73 
contributing to highly accurate control of gene expression both in physiological and 74 
pathological conditions (Cao et al., 2016). As a consequence of SCI, miRNAs purportedly 75 
undergo a sustained change in their expression profile leading to downstream gene regulatory 76 
effects. Potential of miRNAs in the context of SCI lies in the double possibility to exploit them 77 
as diagnostic markers and to manipulate their expression through a mimic/antagomir strategy 78 
(Almurshidi et al., 2019). As key mediators of several neuronal processes both in the brain and 79 
spinal cord, miRNAs are commonly classified into specific functional groups depending on the 80 
role they are exerting. Entire miRNA families or clusters have been attributed to selectively 81 
regulate axon guidance and outgrowth pathways (e.g. miR-430 family, miR-17-92 cluster) at 82 
developmental levels as well as to modulate the inflammation, proliferation, neuroprotection, 83 
apoptosis and regeneration processes after SCI (Nieto-Diaz et al., 2014; Ning et al., 2014). 84 
Immediately after injury, there is a significant increase in the expression of regeneration and 85 
neuroprotection associated genes, a phenomenon controlled by the early activation of specific 86 
transcriptional factors that are regulated by several miRNAs. For example, miR-21, miR-29 87 
and miR-199 (acting on the PTEN/mTOR pathway) have been already described to influence 88 
axonal regrowth after SCI   (Ning et al., 2014; Sun et al., 2018). Strategies that specifically 89 
target one single miRNA or a specific set of miRNAs may promote functional recovery after 90 
SCI (Ghibaudi et al., 2017; Shi et al., 2017). Although the list of miRNAs functionally involved 91 
in axonal regrowth/plasticity is extensive in the literature, there is a lack of experimental 92 
evidence investigating miRNA networks acting on these processes in vivo.  The majority of 93 
non-coding RNAs investigated in SCI studies are generally focused only on the spinal cord, 94 
disregarding the cerebral cortex where CSMNs reside. These cells undergo a structural 95 
remodelling within the cortex that can have a significant impact on the molecular mechanisms 96 
driving the processes after a SCI lesion manifests. 97 
Global identification of sRNAs via library construction and next generation sequencing is 98 
biased for sequences that can readily anneal to adapters with a fixed sequence. miRNAs that 99 





be sequenced. To enhance characterisation of the miRNA population, we used high definition 101 
(HD) adapters that contain four degenerate assigned nucleotides at the ligating ends of HiSeq 102 
2500 adapters. We profiled miRNAs at the cortical level in the acute phase following a 103 
traumatic SCI in order to characterise those involved in the regeneration and neuroprotection 104 
processes. We investigated the sensorimotor cortex of both young and adult mice when 105 
neuronal networks are still refining (P-15) and when the CNS is considered mature and less 106 
plastic (postnatal day 90 or P-90) so to establish an age-related effect. We defined two time 107 
points 12 hours (h) and 3 days (d) after SCI in order to identify those miRNAs acting in the 108 
primary and secondary phase when the therapeutic approaches are more effective. We observed 109 
an upregulation of miR-7b-3p in the cortex of SCI mice. To better understand the role of this 110 
miRNA, we carried out a number of ex vivo and in vitro experiments, finally suggesting that 111 
the regulation of miR-7b-3p could be exploited as a therapeutic target to promote axon 112 
plasticity. 113 
 114 
MATERIALS AND METHODS 115 
 116 
SCI mouse model. C57BL/6J male mice were purchased from Envigo (Udine, Italy). Animals 117 
were maintained under standard conditions with free access to food and water. All experimental 118 
procedures on live animals were performed according to the European Activities Communities 119 
Council Directive of 86/609/EEC 1986 and University of Turin institutional guidelines on 120 
animal welfare (authorisation number 17/2010-B). Postnatal 15 (P-15) and P-90 mice were 121 
divided into two groups: SCI mice (n = 55) and sham controls (n = 61). Mice were anaesthetised 122 
and injured as previously described (Boido et al., 2009). Briefly, the cervical spine was exposed 123 
and spinal muscles were displaced laterally. The lesion was performed by exposing the entire 124 
spinal cord and using a 27-gauge needle, transected at C6 level. In the SHAM group, the spinal 125 
cord was exposed without any damage. 126 
 127 
Histological analysis. A set of animals (P15 n = 15, P90 n = 14) was employed for the 128 
histological analysis of the sensorimotor cortex in order to better characterise the SCI model. 129 
Either 12 h or 3 d after injury both P-15 and P-90 mice were anaesthetised with 3% isoflurane 130 
vaporised in O2/N2O 50:50 and transcardially perfused with 0.1 M PBS, pH 7.4 followed by 131 
4% PFA in PBS. The brain and spinal cord (C6 level) were dissected and post-fixed for 2 h at 132 
4°C in the same fixative solution. Samples were transferred overnight into 30% 0.1M PBS at 133 
4°C then embedded in cryostat medium (Killik, Bio-Optica, Milan, Italy), frozen at -70 °C in 134 
2-methylbutane and cut on the cryostat (Microm HM 550) in coronal and transverse 50 µm 135 
thick sections for brain and spinal cord, respectively. Sections were collected into 1X PBS prior 136 
to immunofluorescence reactions and Fluoro-Jade C (Histo-Chem Inc., Jefferson, Arkansas, 137 
USA) staining.  138 
 139 
Immunofluorescence (IF). For evaluating astrogliosis and microglia activation, sections were 140 
immunolabelled with GFAP and IBA1, respectively. Briefly, after 30 m in PBS-triton 2% and 141 
1 h in blocking solution (0.2% Triton X-100 and 10% normal donkey serum in PBS pH 7.4) 142 
(NDS; Sigma-Aldrich, Milan, Italy), sections were incubated with primary antibodies (IBA1, 143 
Wako Laboratories Chemicals, 019-09741, Japan, 1:500; GFAP, Dako Cytomation, Z0334, 144 
Denmark, 1:500) in the same solution at 4 °C overnight. Then the sections were washed in 1X 145 
PBS and incubated with the secondary antibody (Jackson Immuno Research Laboratories; 146 
1:200 donkey anti-rabbit cyanine 3-coniugated). Images of the sensorimotor cortex were taken 147 
with Nikon DS-5Mc digital camera on a Nikon Eclipse 80i epifluorescence microscope. 148 
Photomicrographs at 40 X magnification were corrected for contrast and brightness 149 
enhancement with ImageJ. 150 





Fluoro-jade C (FJC) staining. To stain degenerating neurons, sections were treated for FJC 152 
staining (Histo-Chem Inc, Jefferson, Arkansas, USA), following supplier’s instructions. Brain 153 
and spinal cord sections were mounted on 2% gelatin coated slides and dried overnight at RT. 154 
The following day, sections were immersed in a solution of 1% sodium hydroxide in 80% 155 
ethanol for 5 m. Then they were rinsed for 2 m in 70% ethanol, 2 m in distilled water and then 156 
incubated in 0.06% potassium permanganate solution in 1X PBS for 10 m. Then slides were 157 
rinsed for 2 m in distilled water and transferred for 20 m to a 0.0004% solution of FJC dissolved 158 
in 0.1% acetic acid. The sections were rinsed in distilled water three times for 1 m before drying 159 
at 37 °C for ~30 m. Dry slides were cleared in xylene for 4 m and covered with an anhydrous 160 
mounting medium. Pictures of sensorimotor cortex were taken on a Nikon DS-5Mc digital 161 
camera on a Nikon Eclipse 80i epifluorescence microscope. 162 
 163 
RNA extraction from sensorimotor cortex samples. The whole sensorimotor cortex was 164 
isolated in order to perform next generation sequencing (n=3). Twelve hours/three days after 165 
injury, SHAM controls (P-15 12 h and 3 d, P-90 12 h and 3 d) and SCI mice (P-15 12 h and 3 166 
d, P-90 12 h and 3 d) in triplicate experiments were sacrificed by cervical dislocation and brains 167 
were removed. We isolated the layer V of the sensorimotor cortices from 1 mm thick coronal 168 
sections obtained using a brain matrix, excluding as much as possible upper and lower layers 169 
and the subcortical white matter. The samples were individually collected and stored at -80 °C. 170 
We extracted RNA as previously described (Valsecchi et al., 2015) using the mirVana 171 
extraction kit following supplier’s instruction (Life Technologies, Milan, Italy). The quality 172 
and quantity of RNA samples was checked by Nanodrop and the samples were stored at -80 173 
°C until small RNA library preparation. Only samples with a 260/280 and 260/230 ratio around 174 
2.1 and 1.8 respectively were used.  175 
 176 
Small RNA library preparation and next generation sequencing. sRNA libraries were 177 
generated using high definition (HD) adapters (Sorefan et al., 2012; Xu et al., 2015). HD 178 
adapters contain four degenerate nucleotides on the ligating ends of 5’ and 3’ Illumina adapters. 179 
HD adapters represent a pool of sequences rather than one fixed sequence, which increases the 180 
annealing efficiency between sRNAs and adapters. Increased annealing efficiency leads to a 181 
greater sRNA complexity in the libraries that are sequenced. Sequencing was performed on a 182 
HiSeq 2500 (Illumina). 183 
 184 
Bioinformatics. Raw FASTQ files were converted to FASTA format. Reads containing 185 
unassigned nucleotides were excluded. The 3′ adapter was trimmed by using perfect sequence 186 
similarity to the first 8 nt of the 3′ HiSeq 2500 adapter (TGGAATTC). The high definition 187 
signatures (four assigned degenerate nucleotides at the ligating ends) of the reads were also 188 
trimmed. sRNAs were mapped full length with no mismatches to the mouse genome 189 
(GRCm38.p6) and then to latest set of mouse miRNA (miRBase (v22) (Kozomara and 190 
Griffiths-Jones, 2014) using PatMaN (62). Normalisation and differential expression analysis 191 
was performed using DESeq2 (v1.2.10) (Love et al., 2014). Independent filtering was used to 192 
remove low-expressing miRNA (< 5) in normalised counts. miRNAs were considered 193 
differentially expressed if they had a p value <0.05, <5% false discovery rate according to the 194 
Benjamini–Hochberg procedure and greater than log2 fold change > 1. 195 
 196 
qPCR. miR-7b-3p, the miRNA with the highest sequencing score across three different groups, 197 
was selected for validation by qPCR. Total RNA was obtained from 3 SCI and 3 SHAM 198 
controls (sequencing samples) plus 5 SCI and 5 SHAM from the P-15 group. We also obtained 199 





for the P-90 group. We used the high capacity cDNA reverse transcription kit (Life 201 
Technologies) following supplier’s instructions. Quantitative PCR (qPCR) was performed with 202 
SYBR green core reagent kit and TaqMan assays (Life Technologies) on a Step-One 2000 PCR 203 
system. miRNA expression was analysed using RNAU6 as a housekeeping gene and t-test as 204 
statistic method. Samples were amplified simultaneously in triplicate in one assay run. 205 
 206 
Functional analysis of miR-7b-3p targets. Functional analysis of miR-7b-3p targets was 207 
performed following two different strategies. Based on the sequence homology of the seed 208 
region between miR-7a-2-3p (5’-CAACAAGUCCCAGUCUGCCACA-3’) and miR-7b-3p 209 
(5’-CAACAAGUCACAGCCAGCCUCA-3’) we selected a list of seven target genes already 210 
validated for miR-7a-2-3p by MiRWalk: Zdhhc9, Wipf2, Cplx1, Basp1, Pfn2, Prkcb and Snca. 211 
These genes are known to be involved in neuronal differentiation. We screened using the 212 
miRWalk PTM the genes predicted to be targets of miR-7b-3p, selecting those genes 213 
recognised by six different databases. DAVID 6.7 was employed to obtain the enriched 214 
annotation terms of the listed genes. We selected 66 genes among the most interesting KEGG 215 
pathways (e.g. axon guidance, negative regulation of anoikis, regulation of actin cytoskeleton, 216 
PI3K-Akt signalling pathway) with p values ≤ 0.05.  217 
 218 
Analysis of miR-7b-3p targets. The putative selected target genes of miR-7b-3p were 219 
validated by qPCR in the experimental groups that showed the highest miRNA level 220 
expression. The same total RNA extracted for miRNA validation was employed to check the 221 
expression of the 7 target genes in P-15 3 d and P-90 3 d groups, the selected 66 genes in P-15 222 
3 d and P-90 12 h groups. cDNA was synthesised using the high capacity cDNA reverse 223 
transcription kit following supplier’s instructions (Qiagen/Life Technologies). Two different 224 
qPCRs were performed: single analysis by SYBR green core reagent kit (Life Technologies, 225 
for the 7 target genes) or custom plates by SYBR green technology (BioRad for 66 selected 226 
genes) in a Step-One 2000 PCR system. Gene expression was analysed using RS18 as a 227 
housekeeping gene. Samples were amplified simultaneously in triplicate in one assay run for 228 
the 7 target list and pulled together (5 SHAM controls vs 5 SCI; t-test as statistic tool) for the 229 
analysis of the 66 selected genes. 230 
 231 
Primary cortical neuron cell culture. In order to study miRNAs of interest in vitro, we 232 
isolated and cultured murine cortical neurons as previously described (Chiotto et al., 2019). 233 
Cells were obtained from murine C57BL/6J brain (n = 6 different embryos each dissection) at 234 
embryonic day 14.5 (E14.5). Cortices were dissected under the microscope and collected in 1X 235 
HBSS supplemented with 0.7% of HEPES and 1% of PS (Invitrogen-Gibco). Cells were 236 
enzymatically dissociated by trypsin-EDTA 0.05% (15 m at 37 °C) and washed in the same 237 
HBSS dissection solution. We then added DNAse (1000U, Promega, Milan, Italy) to the 238 
dissection solution prior to mechanical dissociation by glass Pasteur pipette. Neurons were 239 
counted on a Burker chamber and plated at a density of 32,500 cells/cm2 on Poly-L-Lysine 240 
coated coverslips (0.1 mg/ml poly-L-lysine) in 1X MEM medium supplemented with 20% 241 
glucose, 1% of L-glutamine and 10% of horse serum (Invitrogen-Gibco) and incubated at 37 242 
°C, 5% CO2 and 95% humidity. After 4 h 1X MEM was replaced with Neurobasal 243 
supplemented with 2% of B27 and 1% of L-glutamine (Invitrogen-Gibco). Coverslips with 244 
paraffin dots were placed inverted on the cells to create a suitable environment for neuron 245 
differentiation. Neurons were cultured for 1-18 d. 246 
 247 
Neuro2a cell culture and damage. Neuro2a (N2a) cells were grown in DMEM high glucose 248 
containing 5% FBS, 1% of PS and 1% of L-glutamine (Invitrogen-Gibco). In order to promote 249 
neurite extension, FBS concentration was decreased from 5% to 1% for 72h before inducing 250 




the stress (Fukui et al., 2011). Cells were plated at a density of 32,000 cells/cm2 and were 251 
treated with 0.5 µM of hydrogen peroxide for 24h as oxidative stress, as previously described 252 
(Fukui et al., 2011). The day after the cells were transfected (lipofectamine 2000, Invitrogen) 253 
with 5 nmol of miR-7b-3p mimic (Invitrogen) and after 72h collected for RNA and protein 254 
extraction. 255 
 256 
cell RNA extraction and qPCR. To perform qPCR to measure the expression level of miR-257 
7b-3p, cells were treated as follows: medium was removed and cells were incubated with 258 
trypsin-EDTA 0.05% at 37 °C. Then the detached cells were centrifuged at 1,000 RPM for 5 259 
m, washed with 1X PBS and pellet was stored at -80 °C. RNA was extracted and quantified by 260 
Nanodrop as previously described for in vivo experiments. RNA purification was applied 261 
before performing the qPCR for miR-7b-3p using a solution of 1/10 volume of NH4OAC 262 
(0.5M), 2.5 volume of cold 100% EtOH and 1 ul of glycogen (Invitrogen) for each tube. 263 
Samples were incubated at 80 °C for 30 m and centrifuged at 12,000 g at 4 °C for 20 m. The 264 
supernatant was removed, the pellet washed with 75% cold EtOH and centrifuged again at 265 
12,000 g at 4 °C for 5 m. The pellet was resuspended in DEPC water. RNA samples were stored 266 
at -80 °C before qPCR. qPCR at 1, 7 and 18 d was conducted in triplicate. The qPCR for miR-267 
7b-3p was performed as previously described for in vivo experiments. The expression values 268 
(7 d, 18 d) were normalised to 1 d. 269 
 270 
Nucleofection. Cortical neurons were electroporated immediately after tissue dissociation and 271 
before plating using the rat neuron nucleofector kit (Amaxa, Switzerland). In brief, 500,000 272 
cells were centrifuged for 5 m at 1,000 rpm. After that, supernatant was removed and neurons 273 
were resuspended in 100 µl of Nucleofector solution. Then, 5 nmol of miR-7b-3p mimic 274 
(Invitrogen) per 1x106 cells or negative control (Invitrogen) were added to the suspension 275 
(Buller et al., 2010). Neurons were electroporated with the Amaxa program O-003. Finally, 276 
neurons were plated on poly-L-lysinate coverslip at a final concentration of 32,500 cells/cm2.  277 
 278 
Immunocytochemistry. Three days after nucleofection, cortical neurons grown on coverslips 279 
were fixed with 4% PFA for 15 m and rinsed 3 times in 1X PBS.  Permeabilisation was carried 280 
out with 0.1% TritonX-100/1X PBS for 5 m and non-specific binding sites were blocked by 281 
5% BSA/PBS for 30 m. The following primary antibodies were incubated for 1 h: 1:200 282 
monoclonal mouse anti-SMI-32 (Biolegend, SMI-32P San Diego, California), 1:1,000 283 
monoclonal rabbit anti-βIII-tubulin III (Sigma Aldrich,T8660, St Luois, Missouri) and 1:400 284 
monoclonal cleaved caspase 3 (9664, Cell Signaling). After washing in 1X PBS, primary 285 
antibodies were detected with anti-rabbit or anti-mouse cyanine 3-conjugated secondary 286 
antibodies, anti-rabbit Alexa-596 conjugated secondary antibody and Phalloidin TRITC 287 
(Sigma-Aldrich) 546 (1∶1,000) for 30 m. Once mounted, samples were examined and images 288 
acquired using an Olympus Fluoview 300 confocal laser scanning microscope (CLSM). To 289 
check miR-7b-3p overexpression, qPCR was performed in triplicates on samples at 3 d after 290 
nucleofection. 291 
 292 
In vitro morphometric analysis and evaluation of apoptosis. The images acquired at CLSM 293 
were then analysed with ImageJ software. Five different parameters were measured, (i) axon 294 
length (n = 3), (ii) number of neurites (n = 3), (iii) area of the growth cone (n = 5), (iv) 295 
percentage of the growth cone shape (n = 5) and (v) stage of the neuronal development (n = 4). 296 
Differentiated cells were defined as those bearing at least one neurite longer than twice the cell 297 
body. For each experiment at least 30 axons/neurites were measured. The same cells were also 298 
analysed for the number of dendrites emerging from the cell body. Both measures were 299 




mimic. The area of the growth cones was measured by tracing in ImageJ while the percentage 301 
of the growth cone shape was calculated as the ratio of one growth cone morphology (fork, 302 
hand and stick) on the total number of growth cones. The classification of the stage of neuronal 303 
development (stage I-II-III) was analysed as previously described (Takano et al., 2015). Here 304 
the percentage of neurons at each stage was calculated on the total number of neurons analysed.  305 
As concerns, the analysis of apoptotic signs/markers, the morphology of the nuclei and the 306 
expression of cleaved caspase 3 were analysed. A number > 30 of neurons were analysed in 307 
sham and mimic conditions and results presented as the percentage of apoptotic nuclei or 308 
cleaved caspase 3-positive cells over the total number of nuclei/cells.  309 
 310 
Western blotting. After 72h from the transfection, both primary cortical neurons and N2a were 311 
collected (n=3), the lysate centrifuged and the protein content measured by the BCA protein 312 
assay kit (Invitrogen). Protein extracts (15 µg) were separated on 10% SDS-poly-acrylamide 313 
gels and transferred to PVDF membranes. After washing in Tris-HCl-buffered saline 0.2% 314 
Tween20 (TBST), the membranes were blocked for 1 h at RT in TBST with 5% milk and 315 
eventually incubated with the primary antibody (1:2000 α-actin, A2066; 0.4 µg/ml Wipf2-316 
HPA024467, Sigma Aldrich) overnight at 4ºC. Goat anti-rabbit IgG HRP (Invitrogen) was used 317 
as secondary antibody (1:2000) for 1h at RT. The protein bands were detected with a western 318 
light chemiluminescence detection system (ECL, GE Healthcare Bio-Sciences AB) and 319 
photographed in an ImageQuant LAS 4,000 mini (GE Healthcare Bio-Sciences AB). The 320 
images were analysed by ImageJ, and cropped for presentation. 321 
 322 
Statistical analysis. Data were evaluated as mean ± standard error of mean (SEM). Statistical 323 
analysis was performed using Prism 6.0 (GraphPad, San Diego, CA, USA). For the histological 324 
analysis the percentage of GFAP/IBA1 positive area was quantified using ImageJ and analysed 325 
with a non-parametric t-test (Mann-Whitney). Values p ≤ 0.05 were considered statistically 326 
significant. In the sRNA library preparation and sequencing experiments, the empirical 327 
differential expression analysis was confirmed by parametric (t-tests) and non-parametric 328 
(Mann-Whiney-U) tests. For the statistical tests we considered p < 0.05 as statistically 329 
significant. miRNAs were considered differentially expressed if there was a >0.5 log2 fold 330 
change between controls and treatments, i.e. more than 1.5 fold change. To validate miR-7b-331 
3p and its targets by qPCR, changes in miRNA/gene levels were detected as the difference in 332 
threshold cycle (∆CT) between the target gene and the housekeeping gene. The results were 333 
analysed by Mann-Whitney test and t-test and presented as normalised values between SHAM 334 
controls and SCI groups. In the nucleofection experiments, the statistical analysis was 335 
performed by a non-parametric t-test (Mann-Whitney). For the morphometric analysis t-test 336 
was employed for the axon length, number of neurites and growth cone analysis, the χ2 test was 337 
employed for the neuron stage analysis and values p ≤ 0.05 were considered statistically 338 
significant. The count of apoptotic nuclei and the expression of cleaved caspase 3 was analysed 339 
by t test. In the western blotting the protein bands were analysed by t test and the data presented 340 




SCI triggers neuroinflammation but not evident neuronal degeneration at cortical level. 345 
C57BL/6J male mice underwent a complete spinal cord transection at the cervical level 6 (C6) 346 
by a syringe needle. To characterise this injury model, we analysed the inflammatory reaction 347 
and the presence of degenerating cells in sensorimotor cortex 12 h and 3 d post SCI in both 348 
young (P15) and adult cohorts (P90). The level of microglia activation (IBA-1 positivity) 349 





S1). In adult mice no signs of astrogliosis (GFAP reactivity) were observed in the cortex (data 351 
not shown). Altogether these results suggest that the spinal cord lesion can trigger an 352 
inflammatory response also at cortical level. We did not detect degenerating cells by Fluoro-353 
jade (FJC) staining in the sensorimotor cortex, whereas degenerating cells were markedly 354 
visible in the spinal cord of SCI mice (Figure S2). These results seem to indicate that the lesion 355 
model does not activate a cell death pathway at the cortical level. 356 
 357 
miR-7b-3p is the major upregulated miRNA in SCI-sequencing profile. To evaluate 358 
miRNA differential expression after SCI, a complete transection of the spinal cord was 359 
performed in P-15 and P-90 mice. sRNA sequencing was then performed on isolated layer V 360 
sensorimotor cortex tissue, sampled at 12 h and 3 days after SCI (Figure 1).  361 
To select a candidate miRNA for further investigation, we looked for correlations/relationships 362 
between differentially expressed (DE) miRNAs and groups. Three miRNAs were upregulated 363 
(miR-551b-5p, miR-6481, miR-5126), while four were downregulated (miR-1298-5p, miR-364 
668-3p, miR-671-5p, miR-709) and shared between two groups. Instead miR-7b-3p and miR-365 
26a-1-3p were both upregulated and shared among three groups (P15-12h, P90-12h, P90-3d 366 
and P15-12h P15-3d, P90-12h, respectively). These two miRNAs were found in both young 367 
and adult mice with miR-7b-3p showing the highest fold change (log2 fold change) when 368 
compared to controls (Table 1). This data suggested that miR-7b-3p could perform gene 369 
regulatory functions related to SCI independent of animal age and may have stronger 370 
biological/clinical relevance. To better understand the role of miR-7b-3p, we screened the 371 
literature using Pubmed and miRpub, a specific database collating miRNA-related articles. We 372 
focused on functions related to neurite/axon outgrowth during development, following a lesion 373 
and/or specifically related to SCI. Although some evidence had been reported in the literature 374 
for miR-7b-3p, there were no validated target genes reported in miRWalk (Table 1). 375 
 376 
q-PCR confirmed the upregulation of miR-7b-3p in the cortex of SCI. To confirm the 377 
sequencing results, miR-7b-3p was further analysed by qPCR to confirm its DE in SCI 378 
compared to SHAM controls. A significant upregulated fold change of 2.28 ± 0.37, 1.57 ± 0.85 379 
and 9.8 ± 3.01 times was observed for miR-7b-3p in SCI P-15 12 h, P-90 12 h and P 90 3 d, 380 
respectively, compared to controls (t test, t statistic SHAM vs SCI p < 0.0006 in P-15 12h; p < 381 
0.007 in P-90 12h; p < 0.007 in P-90 3d). We also found that miR-7b-3p expression level was 382 
6.16 ± 2.02 times higher in SCI P-15 3d mice compared to SHAM controls (Figure 2; t test, t 383 
statistic, SHAM vs SCI p < 0.004). The expression of miR-7b-3p increased over time between 384 
12 h and 3 d in both animal age groups. This data suggested that miR-7b-3p could exert a 385 
specific role connected to SCI independently of animal age and time after lesion induction.  386 
 387 
miR-7b-3p targets genes essential for neurite outgrowth. To better investigate the role of 388 
miR-7b-3p in regulating the axon guidance process, we validated several miR-7b-3p target 389 
genes by qPCR. Since the seed sequence is shared between miR-7a-2-3p and miR-7b-3p, we 390 
first analysed the 7 genes already known to be targets of the first miRNA and directly linked 391 
to different neuronal processes (Table S1). As shown in Figure 3, Wipf2 expression (t test, t 392 
statistic p = 0.02) decreased in SCI P-15 3 d animals compared to controls (Figure 3A); Zdhhc9 393 
expression (t test, t statistic p = 0.002) was increased in SCI P-15 3 d (Figure 3A); Prkcb (t test, 394 
t statistic p = 0.04), Wipf2 (t test, t statistic p = 0.02) and Pfn2 (t test, t statistic p = 0.01) were 395 
increased in P-90 3 d SCI mice compared to SHAM controls (SMAH vs SCI). Since Wipf2 is 396 
known to be essential for neurite outgrowth/extension, this result implicates its possibility as a 397 
direct miR-7b-3p target. Considering that Zdhhc9, Prkcb and Pfn2 are linked to axon growth 398 
(Table S1), their upregulation in SCI could represent an indirect link between miR-7b-3p and 399 





We then screened a selected list of genes predicted to be targets of miR-7b-3p by qPCR custom 401 
plates in two of the experimental groups. We chose 66 genes belonging to the following KEGG 402 
pathways: axon guidance, negative regulation of anoikis, regulation of actin cytoskeleton, 403 
PI3K-Akt signaling pathway. Among all the genes analysed, 16 were downregulated in the 404 
cortex of SCI mice and among them, two (G6pc and Ntrk2) were shared between the two 405 
groups (Figure 4). Only some genes have been experimentally demonstrated as key 406 
components of the KEGG pathways. The function of some genes such as G6pc, Ptrh2 and 407 
Itgb3 in this context remains unclear (see Table S2). 408 
 409 
miR-7b-3p is not responsible of neurite outgrowth during in vitro cortical neuron 410 
development. In order to better understand the role of miR-7b-3p, we evaluated whether this 411 
miRNA could be related to the axon growth during cortical neuron development, a function 412 
that could be exploited as potential SCI target (Hilton and Bradke, 2017). We used an in vitro 413 
system to mimic three different time points, 1 d, 7 d and 18 d corresponding to the 414 
undifferentiated neuron stage, dendritogenesis beginning stage and mature neuron stage, 415 
respectively (Figure 5 A). miR-7b-3p expression was constant during neuron development with 416 
slight oscillations among the time groups possibly suggesting its expression change 417 
reactivation only after SCI (Figure 5 A). 418 
To further analyse miR-7b-3p function during development, we studied in vitro the 419 
morphological phenotype of cortical neurons in which we overexpressed this miRNA. Cells 420 
transfected with miR-7b-3p mimic showed a significant upregulation of 3.05 (t test, t statistic 421 
p 0.02) times compared to the negative control transfected cells (Figure 6 A). However, miR-422 
7b-3p overexpression did not change the axon length or the number of neurites (Figure 6 A and 423 
B). These results suggest that miR-7b-3p is not involved in neurite or axon growth during the 424 
cortical development. 425 
 426 
miR-7b-3p maintains the cells in a more plastic stage. Since no validated targets are known 427 
for this miRNA, we performed a functional analysis based on putative targets predicted by (i) 428 
miRWalk algorithm or (ii) miRWalk intersection among 12 different databases. We considered 429 
only those genes predicted by at least 6 databases for DAVID 6.7. Different KEGG and GOBP 430 
neuronal related functions (mainly connected to axon cytoskeleton, neural development and 431 
apoptosis) showed a significant p value (Bonferroni post doc test, p ≤ 0.03, Figure 5 C). Only 432 
two KEGG neuronal functions (axon guidance and regulation of actin cytoskeleton) reached 433 
statistical significance (Figure 5 C). 434 
On the basis of these results, we explored the effect of miR-7b-3p overexpression on the growth 435 
cone area and shape of cortical neurons. However, the total growth cone area was not affected 436 
by the transfection of miR-7b-3p mimic (Figure 7 A). Similarly, the analysis of the ratio of the 437 
growth cone shape (forked, stick, hand) on the total number of growth cone (expressed in 438 
percentage) did not reveal any significant change overexpressing the miRNA (Figure 7 A and 439 
B). 440 
During development cortical neurons switch from a round shape (stage I) to a ramified middle 441 
stage (stage II) and eventually reach the stage III in which the longest branch will become the 442 
axon of the neuron (Figure 8). We analysed the percentage of cells at each stage after mimic 443 
transfection. Interestingly, miR-7b-3p overexpression significantly increased the percentage of 444 
neurons at stage II (χ2 test, p = 0.04) (Figure 8). These results suggest a role of miR-7b-3p in 445 
maintaining the cells in a more immature and, likely plastic, neuronal developmental phase. 446 
 447 
miR-7b-3p reduces apoptosis in primary cortical neurons. The functional analysis based on 448 
putative targets of miR-7b-3p also included the class of genes related to apoptosis. We then 449 





morphology of the nuclei and the expression of cleaved caspase 3 (a well know apoptotic 451 
marker, (Crowley and Waterhouse, 2016). The overexpression of miR-7b-3p resulted in a 452 
significant lower percentage of apoptotic nuclei (Figure 9, t test, t statistic, p = 0.03) and a 453 
reduced expression of cleaved caspase 3 compared to the control cells. This result indicates 454 
that miR-7b-3p can counteract the apoptotic mechanisms and exert a neuroprotective effect.  455 
 456 
In vitro miR-7b-3p overexpression reduces Wipf2 expression in damaged but not in 457 
healthy neurons. We finally investigated the effect of miR-7b-3p overexpression on Wipf2 458 
expression, one of the predicted target genes whose transcript was downregulated in P-15-3d 459 
mice (Figure 3). In healthy primary cortical neurons, the miRNA overexpression does not affect 460 
the Wipf2 protein expression, as shown in Figure 10A. However, N2a cells overexpressing 461 
miR-7b-3p (Figure S3) upon an oxidative stress (H2O2 administration, mimicking the SCI 462 
environment), exhibited a significant decreased expression of Wipf2 (Figure 10B). This result 463 
confirms Wipf2 as a direct target of miR-7b-3p, but only in damage conditions. Therefore, miR-464 
7b-3p can downregulate the expression of neurite growth/regeneration related genes (as Wipf2) 465 
and, once again, this supports the hypothesis that miR-7b-3p can maintain the cells in a more 466 





We investigated the miRNA profile in SCI in order to identify specific miRNAs involved in 472 
regeneration/plasticity. We performed next generation sequencing of the layer V sensorimotor 473 
cortex in both young and adult mice to evaluate miRNA dysregulation 12 h and 3 d after SCI. 474 
The only miRNA significantly upregulated in all of the evaluated conditions was miR-7b-3p, 475 
whose function in spinal cord lesion was the focus of this work.  476 
Several studies analyzed the global profiling of miRNA expression after SCI obtaining 477 
differential expression for a great number of small RNAs (Liu et al., 2009). Some miRNAs 478 
acting on different pathways promote functional recovery. For instance, miR-133b is an 479 
important determinant for axon regrowth and functional recovery by reducing RhoA protein in 480 
an adult zebrafish SCI model (Yu et al., 2011). miR-124 has been demonstrated to control at 481 
least four different pathways (PI3K/AKT, REST, Rho1) all related to axon regrowth after 482 
injury (Ghibaudi et al., 2017). Despite the growing number of miRNAs connected to SCI 483 
condition, we still lack a complete comprehension of this phenomenon.  484 
To identify a wider collection of miRNAs overexpressed/downregulated following SCI, we 485 
performed sRNA library construction with a recently improved technique (Sorefan et al., 2012; 486 
Xu et al., 2015). This method employs high definition (HD) adapters that contain degenerate 487 
nucleotides at their ligating ends, allowing for the formation of more stable secondary 488 
structures between miRNAs and adapters prior to sequencing. Using this approach, sequencing 489 
bias in biological samples can be reduced and the representation of low abundance miRNAs 490 
increases leading to the identification of previously unknown miRNAs. For all the groups 491 
tested, sequencing generated a list of miRNAs potentially dysregulated in SCI cortex compared 492 
to SHAM control groups. Some miRNAs such as miR-7b-3p were reported more than once in 493 
the same group (Table 1). This repetition is due to the fact that slightly different sequences 494 
have been attributed to the same miRNA name. We chose the sequence with the most abundant 495 
number of reads as the most valid, such as in the case of miR-7b-3p. 496 
miRNAs act in a network system in which different members can converge on the same 497 
transcripts (targets), on the same pathways or on the same functions (Barca-Mayo and De Pietri 498 
Tonelli, 2014; Ghibaudi et al., 2017). miRNet analysis did not reveal any significant interaction 499 





15 12 h and 3 d; P-90 12 h and 3 d). A list of 7 miRNAs emerged as potentially related to axon 501 
growth, plasticity and regeneration pathways possibly reactivated after SCI. Consistent with 502 
this hypothesis, among the miRNAs predicted to be up/downregulated, only miR-7b-3p 503 
upregulation was confirmed by qPCR in 3 SCI groups (P-15 12 h and P-90 12 h, 3 d). miR-7b-504 
3p belongs to the evolutionary conserved miR-7 family implicated in the normal function of 505 
different organs (pancreas, heart, skin) with a particular enrichment profile in brain (Horsham 506 
et al., 2015). Indeed, specific RNA binding proteins and transcription factors (hnRNP and Yan) 507 
ensure miR-7 expression in neuronal cells and a refined control of cell differentiation through 508 
a negative feedback loop mechanism (Arora et al., 2013; Choudhury et al., 2013). Consistently 509 
with the functional analysis of the putative predicted targets of miR-7b-3p, we focused on three 510 
gene classes: axon cytoskeleton, neural development and apoptosis. 511 
The role of the miR-7 family in the CNS is heterogeneous ranging from neuroprotective effect 512 
to alleviation of the inflammatory reaction in Parkinson’s disease (PD) and stroke, respectively 513 
(McMillan et al., 2017; Xu et al., 2019b; Zhang et al., 2018). In SCI miR-7 function is poorly 514 
understood. The literature often refers to other members of the miR-7 family that do not share 515 
the same seed region with the miR-7b-3p here analysed. We screened the validated targets 516 
involved in neuronal processes of miR-7a-2-3p that has the same seed region of miR-7b-3p. 517 
Only 4 genes were significantly modulated in SCI conditions. The first gene, Wipf2, is a gene 518 
required for neurite branching and outgrowth, lamellipodia formation and migration (Banzai et 519 
al., 2000; Kakimoto et al., 2004; Kitamura et al., 2003; Suetsugu et al., 2001; Takenawa, 2005; 520 
Xiao et al., 2008) whose level of expression decreased in the P-15 3 d upon miR-7b-3p 521 
upregulation after SCI. This result suggests Wipf2 as a direct target of the miR-7b-3p, that 522 
unexpectedly seems to negatively influencing the axonal regrowth after SCI. This was further 523 
demonstrated by our in vitro experiments (Fig. 10B). On the other hand, Zdhhc9, Prkcb and 524 
Pfn2 were found upregulated in P-15 3 d and P-90 3 d groups. Among their different functions, 525 
all these genes are required in the regulation of actin stability (Da Silva et al., 2003), axon 526 
branching (Han et al., 2015; Holland and Thomas, 2017) and neural maturation and 527 
differentiation (Guo et al., 2012; Kaur et al., 2014), but their role after injury has not been 528 
postulated. Consistently with their known functions and the increased level of expression we 529 
found after SCI, their reactivation can be interpreted as an indirect effect of miR-7b-3p 530 
overexpression. This could therefore indicate the presence of secondary elements controlled by 531 
miR-7b-3p that lead to the reactivation of specific neuronal pathways. 532 
We extended the analysis to those genes predicted by miRWalk as direct targets of miR-7b-3p, 533 
finding that 16 genes were downregulated in the SCI cortex of P-15 3 d and P-90 12 h.  Only 534 
2 of these 16 genes were the genes shared between the young and adult group, G6pc and Ntrk2. 535 
While G6pc role still remain unclear in this specific context (Table S2), Ntrk2 is known to 536 
control neurogenesis and axonal sprouting. miR-7b-3p overexpression decreases the level of 537 
14 other genes in the P-15 3 d group (TableS2). These genes are all involved in developmental 538 
axon guidance, neurite outgrowth and neurogenesis processes at different extents. The fact that 539 
some of them, including Arhgef12, Ephb1 and Pak6, have been already described to be 540 
upregulated in SCI can be ascribed to the different injury models employed and to the tissue in 541 
which the analysis has been conducted. Most of the SCI experiments are focused on the spinal 542 
injured tissue, while we shifted the observation at the cortical level so introducing a different 543 
perspective and revealing new potential targets.  544 
Since it is known that the injured adult CNS re-expresses genes and activates pathways that are 545 
observed during neuronal development (Emery et al., 2003), we explored the function of this 546 
miRNA while this process is occurring. The expression of miR-7b-3p was constant during the 547 
in vitro neuronal developmental steps (Figure 5), as well as its overexpression in primary 548 
cortical neurons did not affect neither axon length nor the number of neurites nor the growth 549 





analysis of the neuronal stages showed that miR-7b-3p mimic increased the percentage of cells 551 
at stage II, a ramified middle stage (Figure 8), representing an intermediate phase of neuronal 552 
development where the cell must still determine which neurite will become the axon. This 553 
result suggests that, eventually also in case of SCI, increased level of miR-7b-3p could make 554 
the damaged neurons more plastic, in an attempt of the cell in refining the growth of neurites. 555 
This mechanism is part of the sprouting process required for a proper regeneration after a lesion 556 
and known to partially involve the reactivation of specific developmental pathways (Hilton and 557 
Bradke, 2017).  558 
Altogether, these results can be actually explained by a complex and subtle role of miR-7b-3p. 559 
Indeed, the regrowth of a severed axon is a spatially and temporally controlled mechanism that 560 
needs to be timely regulated in order to find the most appropriate environmental conditions 561 
(Fawcett, 2020). In this context, it is possible that miR-7b-3p downregulates genes promoting 562 
axon regeneration, maintaining the neurons in a more plastic phase (resembling the in vitro 563 
stage II) redefining the neurite will be the axon.  564 
The conservation of genes involved in the regeneration/plasticity process could also be the key 565 
to explain the absence of differences we observed between the young and the adult SCI groups. 566 
Although at P-90 the nervous system is considered completely mature and less plastic 567 
compared to P-15 (when neuronal networks are still defining), the molecular pathways 568 
promoting the functional recovery after SCI involve neuronal development pathways (such as 569 
Wnt pathway) that are highly evolutionary conserved (Herman et al., 2018; Squair et al., 2018).  570 
Moreover, interestingly, our data suggest another role of miR-7b-3p, linked to neuroprotection. 571 
It has been demonstrated that miR-7 silences pro-apoptotic genes (Pollock et al., 2014), a 572 
functional class that we also observed to be enriched in miR-7b-3p functional analysis (Figure 573 
5C), and protects motor neuron in vitro (Chakrabarti et al., 2014) . It has been recently shown 574 
that miR-7 (member of the same family) exerts a neuroprotective effect in PD directly acting 575 
on α-synuclein and reducing the apoptotic mechanism (Je and Kim, 2017; Salama et al., 2020; 576 
Tarale et al., 2018). These data are in line with our results showing that miR-7b-3p 577 
overexpression reduces the percentage of apoptotic nuclei and the expression level of cleaved 578 
caspase 3 (Figure 9).  579 
Overall, we can hypothesize an intriguing dual role of miR-7b-3p in: i) the induction of a more 580 
plastic neuronal condition/phase, possibly at the expense of the axon regeneration (as also 581 
demonstrated by our in vitro experiments), ii) the neuroprotective role exerted through the 582 
inhibition of the apoptotic cascade. Overall, our findings suggest that increasing the miR-7b-583 
3p levels in case of SCI could reactivate in adult neurons silenced developmental programs, 584 
supporting at the same time the survival of the axotomized neurons. 585 
Lastly, a final consideration on our results is needed to explain the few differences we observed 586 
in our experiments: i) the miRNA sequencing profile we analysed derived from a mixed cell 587 
population also containing astrocytes, microglia and interneurons whose contribution cannot 588 
be totally excluded; ii) the primary cortical neuron model we employed does not fully 589 
recapitulate the pathophysiological phases occurring after SCI, thus probably underestimating 590 




miRNAs emerged as new alternative targets in SCI as they are a potent inner regulatory system 595 
of gene expression that can be manipulated. We laid the groundwork for the future investigation 596 
of the potential roles of miR-7b-3p, whose action can represent an intriguing therapeutic target. 597 
Although these experiments need further confirmation, miR-7b-3p could be linked to the 598 
modulation of plasticity-related genes and to a neuroprotective function, both part of the same 599 





miRNA cannot be considered the most effective therapeutic strategy, but our results allowed 601 
to better understand miRNA mechanisms of action and add new elements to the miRNA 602 
complex network in SCI. A more complete list of long non-coding RNA involved in the 603 
regrowth program will help to design integrative approaches with a stable and successful 604 
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FIGURE LEGENDS 802 
 803 
Figure 1: Deregulated miRNA after SCI. Heat map based on log2 fold change values of 110 804 
DE miRNAs in at least one of the comparisons between cohorts (P15 12 h, P15 3 d, P90 12 h, 805 
P90 3 d) plus corresponding controls. The z score represents the deviation from the mean by 806 
standard deviation units; n=3 for each experimental group. 807 
 808 
 809 
Table 1: miR-7b-3p general information. miRNA functional analysis by miRpub, PubMed and 810 
miRWalk. In the second column, log2 fold change is reported (n=3).  811 
 812 
 813 
Figure 2: miR-7b-3p upregulation following SCI. miR-7b-3p upregulation in all SCI groups 814 
was confirmed by RT-PCR. The graph expresses miRNA normalized relative expression values 815 
± SEM (Mann-Whitney *** p < 0.001; ** p < 0.01; n=8 for each group). 816 
 817 
Figure 3: The targets of miR-7b-3p. A) Two/seven genes were found to be up and 818 
downregulated in P15-3d SCI group, while three/four resulted upregulated in P-90-3d SCI (B). 819 
The graphs express normalised relative expression values (RT-PCR) ± SEM (t-test ** p ≤ 820 
0.002; * p < 0.01; n=5 for each group). 821 
 822 
Figure 4: Custom card of putative miR-7b-3p targets. Downregulated  genes in P-90-12h and 823 
P-15-3d experimental groups. Data are shown as normalized relative expression values of 824 
technical replicates (RT-PCR, n=3 technical replicates; * p ≤ 0.04,** p ≤ 0.09, *** p ≤ 825 
0.0006). 826 
 827 
Figure 5: miR-7b-3p expression and functional analysis in primary cortical neurons. (A) 828 
developing in vitro cortical neurons, DIV-1 undifferentiated neuron stage, DIV-7 829 
dendritogenesis stage, and DIV-18 mature neuron stage; (B) miR-7b-3p expression at DIV-1-830 
7-18 presented as normalized relative expression value compared to DIV-1; (C) enriched 831 
annotation terms with a significant p-value analysed by miRWalk and DAVID 6.7 (n=3; values 832 
expressed as -log10 p-value). 833 
 834 
Figure 6: miR-7b-3p overexpression and its role in neurite outgrowth. (A) miR-7b-3p 835 
overexpression and measurement of axon length (n=3) and number of dendrites (n=3). (B), 836 
comparable axon length and number of dendrites in NC (negative control) and mimic-7b-3p 837 
electroporated cells. Scale bars: (B), 20 µm. The graphs express miRNA normalized relative 838 
expression value, µm for axon length and number for neurites  ± SEM (t-test * p 0.02). 839 
 840 
Figure 7: growth cone analysis in cortical neurons overexpressing miR-7b-3p. (A) 841 





growth cone shape in mimic transfected cells. (B) “hand”, “forked” and “stick” growth cone 843 
shape analyzed in cortical neurons with SMI-32 (neurofilament in white), βIII-tubulin 844 
(cytoskeleton in green), phalloidin (actin in red). Scale bar: 20 µm. The graphs express the 845 
area and the percentage of each type of growth cone/total growth cone number ± SEM (n=5; 846 
t-test n.s.). 847 
 848 
Figure 8: moiR-7b-3p increases the number of neurons in stage II. The number of stage I, II 849 
and III neurons is expressed as a percentage on the total number of neurons analyzed. An 850 
increased stage II number of neurons is shown (n=4; t-test * p ≤ 0.05 for stage II). 851 
 852 
Figure 9: miR-7b-3p reduces the number of apoptotic neurons in vitro. (A) analysis of the 853 
percentage of apoptotic nuclei (% values ± SEM, t test, * p = 0.03) and cleaved caspase 3 in 854 
mimic overexpressing cells. (B) Cleaved caspase 3 expression (red), SMI-32 (green), DAPI 855 
(blue) in CTRL and MIMIC cortical neurons.  856 
 857 
Figure 10: miR-7b-3p overexpression in vitro reduces Wipf2 protein level upon oxidative stress 858 
condition. (A) after miR-7b-3p mimic transfection, the relative expression of Wipf2 protein 859 
was quantified both in primary cortical neurons in healthy state and (B) in N2a cells undergone 860 
oxidative stress condition. 861 
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